Biotechnology Assets SA banner

Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.219 EUR 5.8% Market Closed
Market Cap: €16.4m

Wall St Price Targets

BST Price Targets Summary
Biotechnology Assets SA

There are no price targets for BST.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Biotechnology Assets SA Competitors:
Price Targets
NSIT
Insight Enterprises Inc
7% Upside
1981
Cathay Media and Education Group Inc
61% Upside
AFYA
Afya Ltd
12% Upside

Revenue
Forecast

18% / Year
Past Growth
130% / Year
Estimated Growth
Estimates Accuracy
-96%
Average Miss
18% / Year
Past Growth
130% / Year
Estimated Growth
Estimates Accuracy
-96%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 4 years is 130%.

Gross Profit
Forecast

7% / Year
Past Growth
591% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
7% / Year
Past Growth
591% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 591%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BST's stock price target?
Not Available

BST does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Biotechnology Assets SA?
Projected CAGR
130%

Over the last 13 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 4 years is 130%.

What is the Gross Profit forecast for Biotechnology Assets SA?
Projected CAGR
591%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 591%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett